Financhill
Sell
37

MELI Quote, Financials, Valuation and Earnings

Last price:
$1,722.19
Seasonality move :
5.37%
Day range:
$1,646.00 - $1,727.17
52-week range:
$1,324.99 - $2,161.73
Dividend yield:
0%
P/E ratio:
60.70x
P/S ratio:
4.77x
P/B ratio:
21.79x
Volume:
712K
Avg. volume:
507.7K
1-year change:
7.69%
Market cap:
$87.2B
Revenue:
$14.5B
EPS (TTM):
$28.34
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $2.3B $4B $7.1B $10.5B $14.5B
Revenue Growth (YoY) 59.51% 73.06% 77.88% 49.06% 37.35%
 
Cost of Revenues $1.2B $2.3B $4.1B $5.4B $7.3B
Gross Profit $1.1B $1.7B $3B $5.2B $7.2B
Gross Profit Margin 48% 43.01% 42.51% 49% 49.79%
 
R&D Expenses $223.8M $353M $590M $1.1B $1.8B
Selling, General & Admin $1B $1.1B $1.5B $2B $2.5B
Other Inc / (Exp) -$1.7M -$43M -$109M -$198M -$615M
Operating Expenses $1.3B $1.6B $2.6B $4.1B $5.4B
Operating Income -$153.2M $128M $441M $1B $1.8B
 
Net Interest Expenses -- $4M $91M $56M --
EBT. Incl. Unusual Items -$107.2M $81M $241M $780M $1.6B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $64.8M $82M $149M $298M $569M
Net Income to Company -$172M -$1M $83M $482M $987M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$172M -$1M $83M $482M $987M
 
Basic EPS (Cont. Ops) -$3.71 -$0.08 $1.67 $9.57 $19.64
Diluted EPS (Cont. Ops) -$3.71 -$0.08 $1.67 $9.53 $19.46
Weighted Average Basic Share $48.7M $49.7M $49.8M $50.3M $50.3M
Weighted Average Diluted Share $48.7M $49.7M $49.8M $51.3M $51M
 
EBITDA $32M $293M $674M $1.5B $2.5B
EBIT -$41.4M $188M $470M $1.1B $1.9B
 
Revenue (Reported) $2.3B $4B $7.1B $10.5B $14.5B
Operating Income (Reported) -$153.2M $128M $441M $1B $1.8B
Operating Income (Adjusted) -$41.4M $188M $470M $1.1B $1.9B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $1.1B $1.9B $2.7B $3.9B $5.3B
Revenue Growth (YoY) 85.02% 66.53% 44.78% 45.99% 35.27%
 
Cost of Revenues $635.5M $1.1B $1.3B $1.8B $2.9B
Gross Profit $480.2M $807M $1.3B $2.1B $2.4B
Gross Profit Margin 43.04% 43.43% 50.11% 53.35% 45.92%
 
R&D Expenses $88.8M $138M $278M $396M $504M
Selling, General & Admin $308.3M $404M $486M $637M $871M
Other Inc / (Exp) -$30.4M -$25M -$71M -$239M -$40M
Operating Expenses $397.1M $647M $1.1B $1.3B $1.9B
Operating Income $83.1M $160M $296M $785M $557M
 
Net Interest Expenses -- $9M $27M $15M --
EBT. Incl. Unusual Items $52.7M $126M $198M $531M $520M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $37.6M $31M $69M $172M $123M
Net Income to Company $15M $95M $129M $359M $397M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $15M $95M $129M $359M $397M
 
Basic EPS (Cont. Ops) $0.28 $1.92 $2.57 $7.18 $7.83
Diluted EPS (Cont. Ops) $0.28 $1.92 $2.56 $7.16 $7.83
Weighted Average Basic Share $49.7M $49.6M $50.3M $50M $50.7M
Weighted Average Diluted Share $49.7M $49.6M $51.3M $50.2M $50.7M
 
EBITDA $105.4M $222M $387M $719M $717M
EBIT $77.2M $170M $290M $584M $560M
 
Revenue (Reported) $1.1B $1.9B $2.7B $3.9B $5.3B
Operating Income (Reported) $83.1M $160M $296M $785M $557M
Operating Income (Adjusted) $77.2M $170M $290M $584M $560M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $3.3B $6.3B $9.7B $13.7B $18.5B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $1.8B $3.6B $5.1B $6.7B $10B
Gross Profit $1.5B $2.6B $4.6B $7B $8.5B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $293.5M $528.5M $953M $1.5B $2.1B
Selling, General & Admin $1.2B $1.4B $1.9B $2.3B $3B
Other Inc / (Exp) -$32.4M -$62.5M -$191M -$572M -$239M
Operating Expenses $1.4B $2.2B $3.8B $4.8B $6.7B
Operating Income $83.9M $392.2M $709M $2.2B $1.8B
 
Net Interest Expenses -- $100M $79M $18M --
EBT. Incl. Unusual Items $62.4M $229.7M $439M $1.6B $1.9B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $66.5M $151.5M $158M $648M $462M
Net Income to Company -$4.1M $78.1M $271M $987M $1.4B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$4.1M $78.1M $271M $987M $1.4B
 
Basic EPS (Cont. Ops) -$0.16 $1.59 $5.38 $19.69 $28.35
Diluted EPS (Cont. Ops) -$0.16 $1.59 $5.37 $19.54 $28.34
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $251.9M $606.2M $1.1B $2.4B $2.9B
EBIT $158.6M $436.6M $714M $1.9B $2.3B
 
Revenue (Reported) $3.3B $6.3B $9.7B $13.7B $18.5B
Operating Income (Reported) $83.9M $392.2M $709M $2.2B $1.8B
Operating Income (Adjusted) $158.6M $436.6M $714M $1.9B $2.3B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $2.6B $4.9B $7.5B $10.7B $14.7B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $1.4B $2.8B $3.8B $5.2B $7.9B
Gross Profit $1.2B $2.2B $3.7B $5.5B $6.8B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $235.5M $411M $774M $1.1B $1.4B
Selling, General & Admin $831.9M $1.1B $1.4B $1.8B $2.3B
Other Inc / (Exp) -$32.5M -$52M -$134M -$508M -$132M
Operating Expenses $1.1B $1.7B $3B $3.7B $5B
Operating Income $152.8M $417M $685M $1.9B $1.8B
 
Net Interest Expenses $8.2M $91M $79M $41M $13M
EBT. Incl. Unusual Items $125.3M $274M $472M $1.3B $1.7B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $75.5M $145M $154M $504M $397M
Net Income to Company $49.9M $129M $317M $822M $1.3B
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $49.9M $129M $317M $822M $1.3B
 
Basic EPS (Cont. Ops) $0.95 $2.61 $6.30 $16.41 $25.09
Diluted EPS (Cont. Ops) $0.95 $2.61 $6.29 $16.29 $25.09
Weighted Average Basic Share $149.1M $149.3M $151.1M $150.4M $152.1M
Weighted Average Diluted Share $149.1M $149.3M $152.1M $152.6M $152.1M
 
EBITDA $272.8M $586M $974M $1.8B $2.3B
EBIT $200.4M $449M $693M $1.5B $1.8B
 
Revenue (Reported) $2.6B $4.9B $7.5B $10.7B $14.7B
Operating Income (Reported) $152.8M $417M $685M $1.9B $1.8B
Operating Income (Adjusted) $200.4M $449M $693M $1.5B $1.8B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $1.4B $1.9B $2.6B $1.9B $2.6B
Short Term Investments $1.6B $604.4M $208M $1.1B $1.2B
Accounts Receivable, Net $35.4M $49.7M $98M $130M $156M
Inventory $8.6M $118.1M $253M $152M $238M
Prepaid Expenses $45.3M $87.4M $94M $93M $87M
Other Current Assets $13.5M $13.4M $22M $30M $65M
Total Current Assets $3.8B $5.3B $8.2B $11B $14.3B
 
Property Plant And Equipment $444.7M $694.9M $1.3B $1.6B $2.1B
Long-Term Investments $264M $166.1M $76M $301M $139M
Goodwill $87.6M $85.2M $148M $153M $163M
Other Intangibles $14.3M $14.2M $45M $25M $35M
Other Long-Term Assets $58.2M $67.6M $140M $243M $63M
Total Assets $4.8B $6.5B $10.1B $13.7B $17.6B
 
Accounts Payable $331.1M $728.1M $1B $1.4B $2.1B
Accrued Expenses $35.6M $29.6M -- -- --
Current Portion Of Long-Term Debt $67.8M $46.8M $1.1B $2.1B $2.2B
Current Portion Of Capital Lease Obligations $25.3M $62.6M $102M $156M $201M
Other Current Liabilities $2.1M $21.9M $23M $63M $88M
Total Current Liabilities $1.8B $3.6B $5.8B $8.6B $11.3B
 
Long-Term Debt $624M $844.6M $2.2B $2.6B $2.1B
Capital Leases -- -- -- -- --
Total Liabilities $2.7B $4.9B $8.6B $11.9B $14.6B
 
Common Stock $98.9M $50K -- -- --
Other Common Equity Adj -$406.7M -$468.3M -$515M -$464M -$290M
Common Equity $2B $1.7B $1.5B $1.8B $3.1B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $2.1B $1.7B $1.5B $1.8B $3.1B
 
Total Liabilities and Equity $4.8B $6.5B $10.1B $13.7B $17.6B
Cash and Short Terms $3B $2.5B $2.8B $3B $3.8B
Total Debt $808.1M $1.4B $3.5B $4.7B $4.4B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $1.1B $987.2M $1.5B $2.2B $2.2B
Short Term Investments $2.2B $302.7M $930M $1.6B $1.1B
Accounts Receivable, Net $40.9M $70.5M $108M $161M $216M
Inventory $46.6M $226.7M $160M $246M $322M
Prepaid Expenses $28.4M $52.3M $62M $43M --
Other Current Assets $96.8M $267.9M $276M $313M $464M
Total Current Assets $4.9B $5.3B $9.4B $13.1B $17.8B
 
Property Plant And Equipment $527.8M $1.1B $1.5B $1.9B $2.3B
Long-Term Investments $6.9M $38M $360M $125M $1.2B
Goodwill $79.1M $80.9M $147M $159M $149M
Other Intangibles $14.2M $30.7M $29M $21M $46M
Other Long-Term Assets $45.7M $116.2M $232M $361M $210M
Total Assets $5.7B $6.8B $12B $16.1B $22.6B
 
Accounts Payable $509.1M $906.4M $1.2B $1.9B $2.9B
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt $56.5M $73.3M $1.9B $2.3B $2.2B
Current Portion Of Capital Lease Obligations $41.8M $93.2M $135M $191M $233M
Other Current Liabilities $48.7M $70.2M $121M $143M $296M
Total Current Liabilities $3B $4.3B $7B $10.3B $14.3B
 
Long-Term Debt $612.8M $1.9B $2.7B $2.1B $3B
Capital Leases -- -- -- -- --
Total Liabilities $3.9B $6.7B $10.3B $13.4B $18.6B
 
Common Stock $49.5M $49K -- -- --
Other Common Equity Adj -$509.5M -$496.1M -$527M -$366M -$630M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $1.8B $123M $1.6B $2.7B $4B
 
Total Liabilities and Equity $5.7B $6.8B $12B $16.1B $22.6B
Cash and Short Terms $3.3B $1.3B $2.4B $3.7B $3.3B
Total Debt $1.2B $2.7B $4.6B $4.4B $5.3B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders -$172M -$1M $83M $482M $987M
Depreciation & Amoritzation $73.3M $105M $204M $403M $524M
Stock-Based Compensation $395K $1M -- -- --
Change in Accounts Receivable -$29.8M -$510M -$1.1B -$1.2B -$1.4B
Change in Inventories -$4.1M -$107M -$142M $114M -$69M
Cash From Operations $451.1M $1.2B $965M $2.9B $5.1B
 
Capital Expenditures $136.9M $247M $609M $455M $509M
Cash Acquisitions -- -$7M -$56M -- --
Cash From Investing -$1.4B -$252M -$1.6B -$3.9B -$3.5B
 
Dividends Paid (Ex Special Dividend) -$2.8M -$3M -- -- --
Special Dividend Paid
Long-Term Debt Issued $629.9M $2.4B $9.3B $17B $25B
Long-Term Debt Repaid -$474.9M -$1.8B -$8.7B -$16B -$24.9B
Repurchase of Common Stock -$720K -$54M -$486M -$148M -$356M
Other Financing Activities -$96.4M -$307M $296M -- --
Cash From Financing $2B $242M $1.9B $916M -$267M
 
Beginning Cash (CF) $464.7M $1.5B $2.5B $3.6B $3.4B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $1B $1.2B $1.3B -$15M $1.4B
Ending Cash (CF) $1.5B $2.5B $3.6B $3.4B $3.8B
 
Levered Free Cash Flow $314.2M $935M $356M $2.5B $4.6B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $15M $95M $129M $359M $397M
Depreciation & Amoritzation $28.2M $52M $97M $135M $157M
Stock-Based Compensation $182K -- $1M -- --
Change in Accounts Receivable $19.9M -$293M -$121M -$569M -$487M
Change in Inventories -$26.1M -$67M $21M -$19M -$65M
Cash From Operations $361.3M $265M $724M $941M $1.6B
 
Capital Expenditures $65M $171M $106M $126M $223M
Cash Acquisitions -- -$5M -- -- --
Cash From Investing -$290.1M -$631M -$664M -$1.3B -$2.6B
 
Dividends Paid (Ex Special Dividend) -$1M -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $109.1M $2.6B $5.2B $7.1B $5.3B
Long-Term Debt Repaid -$63.6M -$2.1B -$4.8B -$6.8B -$4.5B
Repurchase of Common Stock -$39M -$298M -$41M -$149M --
Other Financing Activities -$82.7M $295M -- -- --
Cash From Financing -$77.1M $422M $342M $132M $726M
 
Beginning Cash (CF) $1.7B $1.4B $2.3B $3.8B $3.8B
Foreign Exchange Rate Adjustment -$33.3M -$64M -$127M -$311M -$63M
Additions / Reductions -$5.9M $56M $402M -$257M -$282M
Ending Cash (CF) $1.6B $1.4B $2.5B $3.3B $3.5B
 
Levered Free Cash Flow $296.3M $94M $618M $815M $1.4B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders -$4.1M $78.1M $271M $987M $1.4B
Depreciation & Amoritzation $93.2M $169.6M $348M $511M $600M
Stock-Based Compensation $729K $452K $1M -$1M --
Change in Accounts Receivable -$397.4M -$833.9M -$1.3B -$767M -$2.5B
Change in Inventories -$38.5M -$180.7M $74M -$73M -$94M
Cash From Operations $1B $520M $2.1B $4.8B $6.9B
 
Capital Expenditures $196M $541.1M $498M $441M $735M
Cash Acquisitions -$6.9M -$5.1M -$51M -- --
Cash From Investing -$1B -$300.9M -$3.9B -$3.2B -$7.1B
 
Dividends Paid (Ex Special Dividend) -$4M -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $2.3B $6.6B $15.7B $23.9B $18.1B
Long-Term Debt Repaid -$1.8B -$6.6B -$13.9B -$23.9B -$16.9B
Repurchase of Common Stock -$39.7M -$454.3M -$161M -$389M -$1M
Other Financing Activities -- $175.8M -- -- --
Cash From Financing $322.3M -$334.4M $3.2B -$352M $1.3B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $314M -$115.2M $1.4B $1.2B $1.1B
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $808.3M -$21.1M $1.6B $4.3B $6.2B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $49.9M $129M $317M $822M $1.3B
Depreciation & Amoritzation $72.4M $137M $281M $389M $465M
Stock-Based Compensation $548K -- $1M -- --
Change in Accounts Receivable -$300.1M -$624M -$795M -$407M -$1.5B
Change in Inventories -$40.3M -$114M $102M -$85M -$110M
Cash From Operations $926M $264M $1.4B $3.2B $5B
 
Capital Expenditures $159.9M $454M $343M $329M $555M
Cash Acquisitions -$6.9M -$5M -- -- --
Cash From Investing -$838.1M -$887M -$3.2B -$2.5B -$6.2B
 
Dividends Paid (Ex Special Dividend) -$3M -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $1.9B $6.1B $12.5B $19.4B $12.6B
Long-Term Debt Repaid -$1.4B -$6.2B -$11.4B -$19.4B -$11.4B
Repurchase of Common Stock -$39.7M -$440M -$115M -$356M -$1M
Other Financing Activities -$186.8M $296M -- -- --
Cash From Financing $242.4M -$334M $928M -$340M $1.2B
 
Beginning Cash (CF) $4.4B $5.1B $8.3B $10.7B $11.5B
Foreign Exchange Rate Adjustment -$157.5M -$128M -$221M -$443M -$407M
Additions / Reductions $330.2M -$957M -$899M $336M $37M
Ending Cash (CF) $4.6B $4B $7.2B $10.6B $11.1B
 
Levered Free Cash Flow $766.1M -$190M $1.1B $2.9B $4.4B

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock